Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Naphthofluorescein (Naphthafluorescein)是一种 Mint3 抑制剂,具有潜在的抗肿瘤和抗炎活性,抑制 HIF-1 和 Mint3 之间的相互作用,抑制 Mint3 依赖性 HIF-1 活性,抑制癌细胞和巨噬细胞的糖酵解活动,同时未显示出明显的体外细胞毒性和体内副作用。Naphthofluorescein 也是一种荧光 pH 敏感探针,可用于功能性切伦科夫成像。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 255 | 现货 | ||
10 mg | ¥ 412 | 现货 | ||
25 mg | ¥ 742 | 现货 | ||
50 mg | ¥ 1,240 | 现货 |
产品描述 | Naphthofluorescein (Naphthafluorescein) is a Mint3 inhibitor with potential antitumor and anti-inflammatory activities, inhibits the interaction between HIF-1 and Mint3, inhibits Mint3-dependent HIF-1 activity, and inhibits glycolytic activity in cancer cells and macrophages without showing significant in vitro cytotoxicity or in vivo side effects. Naphthofluorescein is also a fluorescent pH-sensitive probe for functional Cherenkov imaging. |
体外活性 | Naphthofluorescein(0-10 μM;24小时;HT1080细胞)在浓度依赖的方式中显著抑制HIF-1报告基因活性。[1] |
体内活性 | Naphthofluorescein (compound 19) (100 mg/kg; i.p.; once daily; 5 days followed by 2 days off for 2 weeks; Male C57BL/6J mice) significantly suppresses the tumour growth of subcutaneously injected E0771 cells and significantly attenuates tumour growth of MDA-MB-231 and AsPC-1 cells in immunodeficient mice. In turn, Naphthofluorescein suppresses tumour growth in human cancer cells in an FIH-1-dependent manner and does not attenuate tumour growth of FIH-1-depleted MDA-MB-231 cells. At the same time, Neither showed weight loss or apparent histological abnormalities in the lung, liver, and kidney nor caused severe adverse effects for at least 2 weeks in mice.[1] |
别名 | Naphthafluorescein |
分子量 | 432.42 |
分子式 | C28H16O5 |
CAS No. | 61419-02-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2 mg/mL
DMSO: 100 mg/mL (231.26 mM), Sonication is recommended.
DMF: 10 mg/mL
DMF:PBS (pH 7) (1:10): 0.09 mg/mL
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3126 mL | 11.5628 mL | 23.1257 mL | 57.8142 mL |
5 mM | 0.4625 mL | 2.3126 mL | 4.6251 mL | 11.5628 mL | |
10 mM | 0.2313 mL | 1.1563 mL | 2.3126 mL | 5.7814 mL | |
20 mM | 0.1156 mL | 0.5781 mL | 1.1563 mL | 2.8907 mL | |
50 mM | 0.0463 mL | 0.2313 mL | 0.4625 mL | 1.1563 mL | |
100 mM | 0.0231 mL | 0.1156 mL | 0.2313 mL | 0.5781 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Naphthofluorescein 61419-02-1 Angiogenesis Chromatin/Epigenetic HIF Naphthafluorescein Inhibitor inhibitor inhibit